Showing 401 - 420 results of 2,381 for search '"labelling"', query time: 0.06s Refine Results
  1. 401

    Study Protocol for the Hand OsteoArthritis Self-Management and Integrated Scheme (OASIS-H) to Improve Outcomes in Patients with Hand Osteoarthritis—an Open-Label Randomized Controlled Trial by Iris Yan Ki Tang, Lai Man Tang, Brian Ho, Joyce Wong, Amanda Lau, Suet Kei Kwok, Carmen Tze Kwan Ho

    Published 2024-12-01
    “…This study examines the efficacy of the Hand OsteoArthritis Self-management and Integrated Scheme (OASIS-H) compared to routine clinical care for patients with symptomatic hand OA. In this open-label, randomized controlled trial, symptomatic OA hand patients are included and randomized into early intervention and routine clinical care groups. …”
    Get full text
    Article
  2. 402

    The Efficacy and Safety of the Chinese Herbal Formula, JTTZ, for the Treatment of Type 2 Diabetes with Obesity and Hyperlipidemia: A Multicenter Randomized, Positive-Controlled, Open-Label Clinical Trial by Xiaotong Yu, Lipeng Xu, Qiang Zhou, Shengping Wu, Jiaxing Tian, Chunli Piao, Hailong Guo, Jun Zhang, Liping Li, Shentao Wu, Meizhen Guo, Yuzhi Hong, Weirong Pu, Xiyan Zhao, Yang Liu, Bing Pang, Zhiping Peng, Song Wang, Fengmei Lian, Xiaolin Tong

    Published 2018-01-01
    “….; and triglycerides (TG) ≥ 1.7 mmol/L) were randomly assigned, in equal proportions, to two groups in this multicenter randomized, positive-controlled, open-label trial. One group received JTTZ formula, and the other received metformin (MET) for 12 consecutive weeks. …”
    Get full text
    Article
  3. 403

    Method for Rapid Labeling of Waste Sludge from a Food Factory with 15N-Glycine and Evaluation of N Use Using Komatsuna (Brassica rapa Var. perviridis) by Mizuho Miura-Ido, Yuzuri Iwamoto, Hiroi Kouya, Yoshihiko Takahashi, Amjad Hassan, Norikuni Ohtake, Hidetaka Hori, Takuji Ohyama

    Published 2021-01-01
    “…To search movement of N from the SF-PMM to plants, we developed a new method to label small amounts of SF-PMM with 15N-glycine. 50 L of wastewater from a food factory was incubated with 1 L of active sludge and 3 g of 15N-glycine (98 atom% 15N), and 175 g of labeled sludge was obtained in a day. …”
    Get full text
    Article
  4. 404
  5. 405

    Label-Free Detection of Human Serum Using Surface-Enhanced Raman Spectroscopy Based on Highly Branched Gold Nanoparticle Substrates for Discrimination of Non-Small Cell Lung Cancer by Xiaowei Cao, Zhenyu Wang, Liyan Bi, Jie Zheng

    Published 2018-01-01
    “…In this study, a potential label-free serum test based on SERS spectroscopy was developed to analyze human serum for the diagnosis of the non-small cell lung cancer (NSCLC). …”
    Get full text
    Article
  6. 406
  7. 407

    HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction by Robin Chung, James C Moon, Alexander R Lyon, Charlotte H Manisty, Muhummad Sohaib Nazir, Malcolm Walker, Peter Kellman, Benjamin Dowsing, Daniel Chen, Jessica Artico, Mark Westwood, Hakim-Moulay Dehbi, Rebecca Roylance, Tom Crake, Peter Schmid, Arjun Ghosh, Maria Sol Andres, Joanna Pedra, Orla Worn

    Published 2025-02-01
    “…The Randomised Controlled Trial for the Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction (HER-SAFE) aims to evaluate whether HFT can be safely withdrawn in non-high cardiovascular (CV) risk patients with ‘recovered’ HER2 CTRCD.Methods and analysis This is a multicentre, open-label randomised controlled trial investigating whether withdrawal of HFT is non-inferior to continuation in non-high CV risk, breast cancer survivors with recovered HER2 CTRCD after cancer treatment completion. …”
    Get full text
    Article
  8. 408

    Clinical efficacy of 0.1% cyclosporine A in dry eye patients with inadequate responses to 0.05% cyclosporine A: a switching, prospective, open-label, multicenter study by Sook Hyun Yoon, Eun Chul Kim, In-Cheon You, Chul Young Choi, Jae Yong Kim, Jong Suk Song, Joon Young Hyon, Hong Kyun Kim, Kyoung Yul Seo

    Published 2025-01-01
    “…Design This study was designed as a switching, prospective, multicenter, 12-week, open-label study. Methods Patients with dry eye disease (DED), who experienced inadequate responses to at least 3 months of treatment with 0.05% cyclosporine, were enrolled in this study. …”
    Get full text
    Article
  9. 409
  10. 410
  11. 411
  12. 412
  13. 413
  14. 414
  15. 415
  16. 416
  17. 417
  18. 418
  19. 419
  20. 420